Can NMN Raise Blood Pressure? What Studies Show
NMN trials show no BP increase; one study found systolic BP dropped ~6 mmHg at 250mg/day over 12 weeks. Long-term cardiac data still limited.
Nad Nmn V2
19 source-based articles maintained by the HealthRX.com Editorial Team.
19articles
5topic areas covered
Jul 14, 2025latest review
Nad Nmn V2 library
Showing 19 of 19 clinical reviews.
NMN and NR After Bariatric Surgery: What the Evidence Actually Shows
A clinician-level review of NMN and NR (nicotinamide mononucleotide and nicotinamide riboside) supplementation after bariatric surgery, covering absorption, dosing, metabolic rationale, and current evidence.
NMN and NR for Bone Health: What the Evidence Actually Shows
A clinician-level review of how NMN and NR (nicotinamide mononucleotide and nicotinamide riboside) affect bone density, osteoblast activity, and fracture risk, with primary-literature citations and dosing context.
NMN and NR for Mental Health and Mood: What the Clinical Evidence Actually Shows
A careful look at how NMN and NR raise NAD+ levels, what that means for brain function, mood, anxiety, and depression, and where the current human trial data stops and mechanistic speculation begins.
NMN and NR for Muscle Preservation: What the Clinical Evidence Actually Shows
A breakdown of NMN and NR (nicotinamide mononucleotide and nicotinamide riboside) as NAD+ precursors for muscle preservation, covering clinical trial data, dosing protocols, and who benefits most.
NMN and NR for Renal Protection: What the Evidence Actually Shows
A clinician-level review of nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) as NAD+ precursors in kidney disease: mechanisms, human trial data, dosing, and real safety signals for renal patients.
NMN and NR in Autoimmune Disease: What Clinicians and Patients Need to Know
A guide to NMN and NR (nicotinamide mononucleotide and nicotinamide riboside) use in autoimmune disease, covering NAD+ biology, immunomodulatory effects, clinical trial data, and practical prescribing considerations.
NMN and NR Microdosing Protocols: What the Clinical Evidence Actually Shows
A guide to NMN and NR microdosing protocols, covering dose ranges tested in human trials, pharmacokinetics, safety data, and what the science does and does not yet support.
NMN and NR Rebound Effects When Stopping: What the Evidence Actually Shows
Can stopping NMN or NR supplementation cause a rebound drop in NAD+ or reversal of benefits? A clinical review of the evidence, withdrawal physiology, and how to taper safely.
NMN and NR Seasonal Use Considerations: What the Evidence Actually Shows
A guide to how season, circadian biology, UV exposure, and metabolic shifts affect NMN and NR dosing strategies, with primary-literature citations throughout.
NMN and NR Sexual Function Impact: What the Clinical Evidence Actually Shows
A deep dive into how NMN and NR supplementation affects sexual function, hormone balance, vascular health, and libido through NAD+ pathway biology. Includes clinical trial data, dosing guidance, and evidence-based expectations.
NMN and NR: Appetite and Cravings Changes Explained
Does NMN or NR affect appetite and food cravings? This MD-reviewed guide covers the mechanistic science, human trial data, and clinical context for nicotinamide mononucleotide and nicotinamide riboside on hunger regulation.
NMN and NR: Compounded vs. Branded, What the Evidence Actually Shows
A clinician-level comparison of compounded and branded nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR): bioavailability, purity, regulatory status, cost, and how to choose based on current trial data.
NMN and NR: How Nicotinamide Mononucleotide and Riboside Affect Metabolism and Energy Expenditure
A clinical deep-dive into how NMN and NR raise NAD+ levels, influence mitochondrial function, insulin sensitivity, and whole-body energy expenditure, with primary-literature citations and dosing guidance.
NMN and NR: What Do They Actually Do to Your Liver?
A clinician-level review of how NMN and NR (nicotinamide mononucleotide and nicotinamide riboside) affect liver function, NAD+ metabolism, NAFLD/MASLD pathways, and safety signals from human trials.
NMN and NR: What They Actually Do to Your Hair and Skin
A deep dive into the clinical evidence for nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) effects on hair growth, skin aging, pigmentation, and barrier function, with real trial data and dosing guidance.
NMN, Muscle Insulin Sensitivity in Prediabetic Women (PubMed)
Yoshino 2021 RCT (N=25): NMN improved muscle insulin sensitivity in postmenopausal prediabetic women, GRADE Moderate. Other NMN/NR outcomes rate Low to Very Low.
NMN/NR (Nicotinamide Mononucleotide/Riboside) Cancer Risk Signal Review
A physician-level review of the cancer risk signals associated with NMN and NR supplementation, covering NAD+ biology, preclinical tumor-promotion data, clinical trial safety reports, and practical guidance for patients and prescribers.
Restarting NMN or NR After Acute Illness: A Clinical Guide
Evidence-based protocol for resuming nicotinamide mononucleotide (NMN) or nicotinamide riboside (NR) supplementation after acute illness, with dosing guidance, timing, contraindications, and the latest trial data.